Saturday 31 March 2018 photo 22/30
|
Guided therapeutics inc: >> http://wdx.cloudz.pw/download?file=guided+therapeutics+inc << (Download)
Guided therapeutics inc: >> http://wdx.cloudz.pw/read?file=guided+therapeutics+inc << (Read Online)
Learn about working at Guided Therapeutics inc.. Join LinkedIn today for free. See who you know at Guided Therapeutics inc., leverage your professional network, and get hired.
Stock analysis for Guided Therapeutics Inc (GTHP:OTC BB) including stock price, stock chart, company news, key statistics, fundamentals and company profile.
Company Name: Guided Therapeutics Inc, Stock Symbol: GTHP, Industry: Medical - Healthcare, Total Posts: 4942, Last Post: 3/31/2018 6:36:58 AM.
Guided Therapeutics, Inc., is the maker of the LuViva® Advanced Cervical Scan, a platform technology for the early detection of disease that leads to cancer. Based on our patented biophotonic technology, the products use light to detect disease at the cellular level and provide painless and immediate results at the time of
Guided Therapeutics, Inc. has developed a platform technology for the early detection of disease that leads to cancer. Based on our patented biophotonic technology, the products use light to detect disease at the cellular level and provide painless and immediate results at the time of the examination. Testing for cancer
Guided Therapeutics, Inc., a medical technology company, focuses on developing medical devices to enhance healthcare. Its technology, including products in research and development, primarily relates to biophotonics technology for the non-invasive detection of cancers. The company is developing LuViva,
Guided Therapeutics Signs Preliminary License Agreement with Turkish Distribution Partner Based on Ministry of Health Support for the LuViva Advanced Cervical Scan. Guided Therapeutics, Inc. , the maker of a rapid and painless testing platform based on its patented biophotonic technology, announced today that it has
LuViva in the News. Guided Therapeutics Ships 8 LuViva Devices and 4,500 Single Use Cervical Guides to Indonesia in Q4 2017. Guided Therapeutics Re-establishes Communications with U.S. FDA and Discusses Plan for Refiling for Approval of the LuViva® Advanced Cervical Scan.
1 Mar 2018 NORCROSS, Ga.--(BUSINESS WIRE)--Guided Therapeutics, Inc. (OTCQB: GTHP) reported today record sales for a quarter in Indonesia, with eight LuViva® Advanced Cervical Scans shipped in the fourth quarter of last year. In addition, Indonesia ordered 4,500 single-use Cervical Guides which were
Guided Therapeutics, Inc. (OTCQB: GTHP) is the maker of a rapid and painless testing platform for the early detection of disease based on its patented biophotonic technology. The company’s first product is the LuViva® Advanced Cervical Scan, a non-invasive device used to detect
Annons


Visa toppen
Show footer